Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2707]
News [7027]
Articles [265]
Editorials [8]
Conferences [213]
elearning [41]
6-factor prognostic model for patients with advanced urothelial carcinoma
Dr Gregory Pond - McMaster University, Hamilton, Ontario
6-factor prognostic model for patients with advanced urothelial carcinoma ( Dr Gregory Pond - McMaster University, Hamilton, Ontario )
9 Feb 2018
Comment: Urothelial cancer research from ASCO GU 2018
Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA
Comment: Urothelial cancer research from ASCO GU 2018 ( Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA )
9 Feb 2018
Genomic profiling of muscle invasive bladder cancer to predict response to...
Dr David Miyamoto - Massachusetts General Hospital, Boston, USA
Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy ( Dr David Miyamoto - Massachusetts General Hospital, Boston, USA )
9 Feb 2018
Tumour fraction in circulating free DNA as a biomarker of disease dynamics in...
Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA
Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer ( Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA )
9 Feb 2018
Crizotinib for advanced papillary renal cell carcinoma with MET mutations or...
Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium
Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amplification ( Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium )
9 Feb 2018
Serum miRNA to predict post-chemotherapy viable disease in testicular non...
Dr Ricardo Leão - University of Toronto, Toronto, Canada
Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumour patients ( Dr Ricardo Leão - University of Toronto, Toronto, Canada )
8 Feb 2018
Radium-223 for bone predominant metastatic castration resistant prostate cancer
Dr Andrew Armstrong - Duke University School of Medicine, Durham, USA
Radium-223 for bone predominant metastatic castration resistant prostate cancer ( Dr Andrew Armstrong - Duke University School of Medicine, Durham, USA )
8 Feb 2018
Latest in adjuvant therapy for renal cell carcinoma
Dr Naomi Haas - University of Pennsylvania, Philadelphia, USA
Latest in adjuvant therapy for renal cell carcinoma ( Dr Naomi Haas - University of Pennsylvania, Philadelphia, USA )
8 Feb 2018
Updates in metastatic prostate cancer
Prof Heather Payne, Dr Neal Shore, Dr Eleni Efstathiou, Prof Nicolas Mottet
Updates in metastatic prostate cancer ( Prof Heather Payne, Dr Neal Shore, Dr Eleni Efstathiou, Prof Nicolas Mottet )
8 Feb 2018
Hypoxia related mRNA biomarker to predict biochemical failure and metastasis...
Dr Ananya Choudhury - The Christie NHS Foundation Trust, Manchester, UK
Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer ( Dr Ananya Choudhury - The Christie NHS Foundation Trust, Manchester, UK )
8 Feb 2018
Detection and clinical significance of dense breast tissue
Prof Wendy Ingman - The University of Adelaide, Adelaide, Australia
Detection and clinical significance of dense breast tissue ( Prof Wendy Ingman - The University of Adelaide, Adelaide, Australia )
6 Feb 2018
Challenges in cervical radiotherapy
Prof Fady Geara - American University of Beirut Medical Center, Beirut, Lebanon
Challenges in cervical radiotherapy ( Prof Fady Geara - American University of Beirut Medical Center, Beirut, Lebanon )
29 Jan 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation